ECTRIMS

🎥 🍿 Direct from the auditorium of this year's Opening Session, ECTRIMS is proud to share our 40th anniversary film: "What is ECTRIMS?" This short film traces the rich history of ECTRIMS. It starts with the vision of one of our pioneering founders, Professor Otto R. Hommes. And it ends with a tribute to our collective achievements, the incredible progress we’ve made since our humble beginnings, and the community we’ve built over the last four decades. Thank you for being part of this incredible journey #ECTRIMS2024 PLAY HERE 👉 https://bit.ly/3MWzrJQ ___________ Featuring: Bernard Uitdehaag Amsterdam UMC | Frederik Barkhof VU University Medical Center - Amsterdam Neuroscience | Maria Pia Amato Università degli Studi di Firenze | Xavier Montalban CEMCAT (Centre d'Esclerosi Múltiple de Catalunya) | Alan J Thompson UCL | Ludwig Kappos University Hospital Basel | maria trojano Università degli Studi di Bari | Mar Tintore Subirana CEMCAT (Centre d'Esclerosi Múltiple de Catalunya) | Powered by Congrex Switzerland

🔬 🌐 The revised McDonald Criteria for diagnosing #MS are set to enhance diagnostic accuracy and speed. We are therefore thrilled to launch our new website dedicated to these updates and everything you need to know about the criteria. Whether you're a healthcare professional, researcher, or patient, our resources are designed to keep you informed and at the forefront. More information can be found at https://bit.ly/40rtPzz 🎥 Plus, don't miss the opportunity to access a special scientific session with Prof. Xavier Montalban at #ECTRIMS2024 discussing these revisions, available until 31 January 2025 on our on-demand platform: https://bit.ly/3AXBzOQ #MultipleSclerosis #McDonaldCriteria #diagnosis National MS Society

🌟 Are you a dedicated young healthcare professional eager to excel in your field? Don’t miss out — the deadline to apply for the ECTRIMS fellowship programmes – 1 December 2024 – is fast approaching! ⏰ Discover how the ECTRIMS fellowships can accelerate your career and submit your application today ➡️ https://lnkd.in/exYYXvdg 🎓 Clinical Fellowship: Acquire specialised skills, collaborate with academia & industry leaders, and propel your clinical career to new heights. 🎓 Research Fellowship: Lead groundbreaking research, contribute to medical advancements, and become a thought leader in your domain. 🎓 Nurses & AHP Professionals Training: Elevate your expertise, enhance patient care, and open doors to diverse career opportunities. 🎓 MAGNIMS-ECTRIMS Fellowship: Utilize cutting-edge magnetic resonance techniques to advance your expertise in multiple sclerosis studies. 🎓 MEDEN-ECTRIMS Fellowship: Gain invaluable clinical experience in neuromyelitis optica spectrum disorders (#NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorder (#MOGAD). #ms #msresearch #fellowships #nurses #AHP

📢 Happening today! ☑️ It's not too late to sign up for our free webinar at 18:30-19:30 CET to discuss the results of a groundbreaking global initiative to deepen our understanding of the unmet needs of women living with MS. 🌍 The initiative was supported by the International Advisory Committee on Clinical Trials in MS – a global group of leaders in clinical trials and research sponsored by ECTRIMS and the National MS Society. Don't miss the chance to hear from Prof. Mar Tintore of CEMCAT (Centre d'Esclerosi Múltiple de Catalunya), Prof. Ruth Anne Marrie of Dalhousie University and Dr. Lindsay Ross of Cleveland Clinic - who will share key takeaways from the scoping review as well as discuss the continued gaps in knowledge, considerations around clinical management of women living with MS, and strategy. Moderated by Rachel Horne, journalist and founder of the Rachel Horne Prize. Register here!➡️ https://bit.ly/48HlVUR #MS #webinar #Women'sHealth

⏰ One day to go -- ready to deep dive into the unmet needs of women with MS? 🗓️ Join our free webinar tomorrow, Tuesday, 5 November at 18:30-19:30 CET as experts discuss the results of a groundbreaking global initiative to deepen our understanding of the knowledge gaps and prioritisation of issues affecting women living with MS. 🌍 The initiative was supported by the International Advisory Committee on Clinical Trials in MS – a global group of leaders in clinical trials and research sponsored by ECTRIMS and the National MS Society. Don't miss the chance to hear from Prof. Mar Tintore of CEMCAT (Centre d'Esclerosi Múltiple de Catalunya), Prof. Ruth Anne Marrie of Dalhousie University and Dr. Lindsay Ross of Cleveland Clinic - who will share key takeaways from the scoping review as well as discuss the continued gaps in knowledge, considerations around clinical management of women living with MS, and strategy. Moderated by Rachel Horne, journalist and founder of the Rachel Horne Prize. Register now! ➡️ https://bit.ly/48HlVUR #MS #webinar #Women'sHealth

📣 Join us in exploring the insightful Q&A from this year’s ECTRIMS Patient Community Day! We had an incredible turnout with nearly 500 questions from participants eager to delve into the latest research on multiple sclerosis and related disorders. While our expert panelists answered many during the live event, several questions remained unanswered. To ensure everyone has access to this valuable information, we’ve organised the questions and answers by key topics. A heartfelt thank you to our host and moderator, Brett Drummond of MStranslate, for his commitment to reviewing and coordinating these responses. 💡 You will find our Q&A section here: https://bit.ly/4562FhC #ECTRIMS4me #ECTRIMSPatientCommunityDay #PatientEvent #MS #MOGAD #NMOSD

👩What are the unmet needs of women with MS? 🗓️ Join our next webinar on Tuesday, 5 November at 18:30-19:30 CET as our panel of experts unpacks the results of a groundbreaking global initiative to deepen our understanding of the knowledge gaps and prioritisation of issues affecting women living with MS. 🌍 The initiative was supported by the International Advisory Committee on Clinical Trials in MS – a global group of leaders in clinical trials and research sponsored by ECTRIMS and the National Multiple Sclerosis Society. Don't miss the chance to hear Prof. Mar Tintore of CEMCAT (Centre d'Esclerosi Múltiple de Catalunya), Prof. Ruth Anne Marrie of Dalhousie University & Dr. Lindsay Ross of Cleveland Clinic - who will share key takeaways from the scoping review as well as discuss the continued gaps in knowledge, considerations around clinical management of women living with MS, and strategy. Moderated by Rachel Horne. The webinar is free, but registration is required. Sign up now! ➡️ https://bit.ly/48HlVUR #MS #webinar #Women'sHealth #women

🩺The diagnostic criteria for multiple sclerosis (MS) are changing! Get the resources you need to stay on top of the revisions aimed at making it easier to diagnose MS more quickly and accurately. Visit our new online hub dedicated to the McDonald Diagnostic Criteria to: 📌 Read the initial recommendations of the International Advisory Committee on Clinical Trials in MS 🎧 Listen to our podcast with Committe Chair Prof. Xavier Montalban of CEMCAT (Centre d'Esclerosi Múltiple de Catalunya) 📺 Watch our video featuring Prof. Montalban Know the latest on the #MS diagnostic criteria - explore these resources now ➡️ https://bit.ly/40rtPzz #MS #diagnosis National MS Society

📖 What notable findings in multiple sclerosis (MS) research have been published over the past month? 💫 In our latest MS Research Updates, we highlight these new findings and more: 🔬 Researchers found specific CD8+ T cell dysregulation that may drive the disease already early, in prodromal stages. This discovery could help identify MS before clinical onset and pave the way for new treatments. 💊Two phase-3 clinical trials found evobrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor, was not more effective than teriflunomide in reducing relapses or disability in relapsing MS. Published in The Lancet Neurology, the study also found evobrutinib was generally well tolerated, but was associated with more frequent elevations in liver aminotransferase levels compared to teriflunomide. 🧠 A new study by researchers from Amsterdam UMC – MS Centrum Amsterdam shows switching between brain states costs more energy in individuals with MS and cognitive impairment. They spend more time in the "default mode network" – engaged at rest or during moments of self-directed thinking – and less in the "visual network." The latest MS research developments are just a click away. Read our latest MS Research Updates ➡️ https://bit.ly/3UmDcwA Subscribe to the MS Research Updates ➡️ https://bit.ly/3o37zrL #MS #MSresearch #Neurology #Women’sHealth #CognitiveImpairment

👩What are the unmet needs of women with MS? 🗓️ Join our upcoming webinar on 5 November at 18:30-19:30 CET as our panel of experts discusses the results of a groundbreaking global initiative to deepen our understanding of the knowledge gaps and prioritisation of issues affecting women living with MS. 🌍 The initiative was supported by the International Advisory Committee on Clinical Trials in MS – a global group of leaders in clinical trials and research sponsored by ECTRIMS and the National MS Society. Don't miss the chance to hear from Prof. Mar Tintore Subirana of CEMCAT (Centre d'Esclerosi Múltiple de Catalunya), Prof. Ruth Anne Marrie of Dalhousie University & Dr. Lindsay Ross of Cleveland Clinic - who will share key takeaways from the scoping review as well as discuss the continued gaps in knowledge, considerations around clinical management of women living with MS, and strategy. Moderated by Rachel Horne, journalist and founder of the Rachel Horne Prize. The webinar is only a week away (5 November) - register now! ➡️ https://bit.ly/48HlVUR #MS #webinar #Women'sHealth